Do Fetal Microchimeric Cells Influence Experimental Autoimmune Myocarditis?

Area of Science:

• Immunology
• Cardiovascular Research
• Reproductive Biology

Background:

• Fetal microchimerism involves the exchange of cells between mother and fetus.
• Experimental autoimmune myocarditis (EAM) is an immune-mediated cardiac disease.
• The role of fetal microchimerism in maternal immune responses, particularly in cardiac conditions, remains incompletely understood.

Purpose of the Study:

• To investigate the presence and influence of fetal microchimerism in the cardiac tissue of female mice with experimental autoimmune myocarditis.
• To compare the immune response and cardiac inflammation in nulliparous, syngeneically mated, and allogeneically mated female mice subjected to EAM.

Main Methods:

• Female BALB/c mice (nulliparous, syngeneic mating, or allogeneic mating with C57BL/6 males) were immunized with cardiac myosin peptide MyHC-α614-629 or served as controls.
• Immunization was performed 6-8 weeks postpartum, and mice were assessed 21 days later.
• Cardiac tissue was analyzed for inflammatory infiltrate, fibroplasia, anti-MyHC-α614-629 antibody levels, and the frequency of microchimeric fetal cells.

Main Results:

• Allogeneically mated, immunized mice exhibited lower anti-MyHC-α614-629 antibody production compared to immunized nulliparous mice.
• Immunized nulliparous females showed intense cardiac mononuclear inflammatory infiltrate and fibroplasia.
• Mated females, particularly those from allogeneic mating, displayed a reduced inflammatory reaction and an increased frequency of microchimeric fetal cells in cardiac tissue post-immunization.

Conclusions:

• Allogeneic fetal microchimeric cells in the maternal cardiac tissue may play a role in mitigating the inflammatory response during experimental autoimmune myocarditis.
• The presence of fetal microchimerism, especially from allogeneic pregnancies, could offer a protective effect against autoimmune cardiac inflammation.